LEADER 01381nam0-2200373---450-
001 990008306120403321
005 20060627104439.0
010   $a0-913595-05-5
035   $a000830612
035   $aFED01000830612
035   $a(Aleph)000830612FED01
035   $a000830612
100   $a20060331d1984----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $aa-------001yy
200 1 $a<<The >>United States pharmacopeia$etwenty-first revision$eofficial from January 1, 1985$a<<The >>National formulary$esixteenth edition$eofficial from January 1, 1985$fby authority of the United States Pharmacopeial Convention
210   $aRockville$cUnited States Pharmacopeial Convention$d1984
215   $aLVII, 1683 p.$d30 cm
304   $aTitoli del controfront.: USP 21 : The pharmacopeia of the United States of America; NF 16 : The National Formulary
517 1 $aUSP 21
517 1 $a<<The >>pharmacopoeia of the United States of America
517 1 $aNF 16
610 0 $aFarmacopee$aStati Uniti d'America
676   $a615.1173
710 02$aUnited States pharmacopeial convention$017305
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008306120403321
952   $a80 XXIII A 86 CFT (1)$bCFT 044$fFFABC
959   $aFFABC
996   $aUnited States pharmacopeia$9396780
996   $aNational formulary$9745143
997   $aUNINA